272 related articles for article (PubMed ID: 22439844)
1. Adenosine A(2a) receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats.
Imarisio C; Alchera E; Sutti S; Valente G; Boccafoschi F; Albano E; Carini R
Clin Sci (Lond); 2012 Sep; 123(5):323-32. PubMed ID: 22439844
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicity.
Alchera E; Rolla S; Imarisio C; Bardina V; Valente G; Novelli F; Carini R
Transl Res; 2017 Apr; 182():75-87. PubMed ID: 28011152
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of JNK along with activation of ERK1/2 MAPK pathways improve steatohepatitis among the rats.
Aghazadeh S; Yazdanparast R
Clin Nutr; 2010 Jun; 29(3):381-5. PubMed ID: 19748164
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
5. Adenosine-dependent activation of hypoxia-inducible factor-1 induces late preconditioning in liver cells.
Alchera E; Tacchini L; Imarisio C; Dal Ponte C; De Ponti C; Gammella E; Cairo G; Albano E; Carini R
Hepatology; 2008 Jul; 48(1):230-9. PubMed ID: 18506850
[TBL] [Abstract][Full Text] [Related]
6. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.
Locatelli I; Sutti S; Vacchiano M; Bozzola C; Albano E
Clin Sci (Lond); 2013 Feb; 124(4):279-87. PubMed ID: 22970906
[TBL] [Abstract][Full Text] [Related]
7. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice.
Min AK; Kim MK; Kim HS; Seo HY; Lee KU; Kim JG; Park KG; Lee IK
Life Sci; 2012 Jan; 90(5-6):200-5. PubMed ID: 22154902
[TBL] [Abstract][Full Text] [Related]
8. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis.
Salamone F; Galvano F; Cappello F; Mangiameli A; Barbagallo I; Li Volti G
Transl Res; 2012 Jun; 159(6):477-86. PubMed ID: 22633099
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological postconditioning protects against hepatic ischemia/reperfusion injury.
Dal Ponte C; Alchera E; Follenzi A; Imarisio C; Prat M; Albano E; Carini R
Liver Transpl; 2011 Apr; 17(4):474-82. PubMed ID: 21445931
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
[TBL] [Abstract][Full Text] [Related]
11. Prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction.
Jun DW; Cho WK; Jun JH; Kwon HJ; Jang KS; Kim HJ; Jeon HJ; Lee KN; Lee HL; Lee OY; Yoon BC; Choi HS; Hahm JS; Lee MH
Liver Int; 2011 Oct; 31(9):1315-24. PubMed ID: 22093454
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis.
Beraza N; Malato Y; Vander Borght S; Liedtke C; Wasmuth HE; Dreano M; de Vos R; Roskams T; Trautwein C
Gut; 2008 May; 57(5):655-63. PubMed ID: 18408102
[TBL] [Abstract][Full Text] [Related]
13. Anti-apoptotic and anti-inflammatory effects of Silybum marianum in treatment of experimental steatohepatitis.
Aghazadeh S; Amini R; Yazdanparast R; Ghaffari SH
Exp Toxicol Pathol; 2011 Sep; 63(6):569-74. PubMed ID: 20471811
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.
Kawaguchi K; Sakaida I; Tsuchiya M; Omori K; Takami T; Okita K
Biochem Biophys Res Commun; 2004 Feb; 315(1):187-95. PubMed ID: 15013444
[TBL] [Abstract][Full Text] [Related]
15. Ischemia/Reperfusion Injury of Fatty Liver Is Protected by A2AR and Exacerbated by A1R Stimulation through Opposite Effects on ASK1 Activation.
Alchera E; Chandrashekar BR; Clemente N; Borroni E; Boldorini R; Carini R
Cells; 2021 Nov; 10(11):. PubMed ID: 34831394
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms.
Ji G; Yang Q; Hao J; Guo L; Chen X; Hu J; Leng L; Jiang Z
Int Immunopharmacol; 2011 Jun; 11(6):762-8. PubMed ID: 21320636
[TBL] [Abstract][Full Text] [Related]
17. [The role of apoptosis and the related genes in non-alcoholic steatohepatitis].
Nan YM; Wu WJ; Yao XX; Wang L
Zhonghua Gan Zang Bing Za Zhi; 2007 Jan; 15(1):41-6. PubMed ID: 17244458
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM
J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
[TBL] [Abstract][Full Text] [Related]
19. Activation of the adenosine A2A receptor attenuates experimental autoimmune myasthenia gravis severity.
Li N; Mu L; Wang J; Zhang J; Xie X; Kong Q; Tang W; Yao X; Liu Y; Wang L; Wang G; Wang D; Jin L; Sun B; Li H
Eur J Immunol; 2012 May; 42(5):1140-51. PubMed ID: 22539289
[TBL] [Abstract][Full Text] [Related]
20. Roles of phosphatidylinositol 3-kinase and osteopontin in steatosis and aminotransferase release by hepatocytes treated with methionine-choline-deficient medium.
Sahai A; Pan X; Paul R; Malladi P; Kohli R; Whitington PF
Am J Physiol Gastrointest Liver Physiol; 2006 Jul; 291(1):G55-62. PubMed ID: 16439472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
